Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Link opens in a new tab
Search content at Icahn School of Medicine at Mount Sinai
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Prevalence of Chronic Hepatitis B Virus Infection in the United States
Joseph K. Lim
, Mindie H. Nguyen
, W. Ray Kim
, Robert Gish
, Ponni Perumalswami
, Ira M. Jacobson
CTSA ConduITS - Institutes for Translational Sciences
Research output
:
Contribution to journal
›
Review article
›
peer-review
144
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Prevalence of Chronic Hepatitis B Virus Infection in the United States'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
United States
100%
Chronic Hepatitis B Virus Infection
100%
Hepatitis B Virus
33%
Virus Prevalence
33%
Chronic Hepatitis B Virus
33%
Hepatocellular Carcinoma
16%
Vaccination
16%
Liver Disease
16%
Hepatologist
16%
Global Health Issue
16%
Health Care Services
16%
Chronic Liver Disease
16%
Panel Member
16%
Liver Cirrhosis
16%
Epidemiology
16%
Clinical Complications
16%
Prevalence Estimation
16%
World Health Organization
16%
Health Departments
16%
Peer-reviewed Literature
16%
Human Services
16%
Future Initiative
16%
Virus Prevention
16%
Hepatitis B Virus Screening
16%
State Department
16%
Existing Resources
16%
Raising Awareness
16%
Educational Organization
16%
Range Estimate
16%
501(c)(3)
16%
Hepatitis Elimination
16%
Hepatitis B Virus Epidemiology
16%
Nursing and Health Professions
Prevalence
100%
Chronic Hepatitis B
100%
Hepatitis B
80%
Liver Disease
20%
Hepatologist
20%
Liver Cell Carcinoma
20%
Liver Cirrhosis
20%
Literature Review
20%
Chronic Liver Disease
20%
Diseases
20%
World Health Organization
20%
Medicine and Dentistry
Prevalence
100%
Hepatitis B Virus
100%
Chronic Hepatitis B
100%
Cohort Effect
33%
Hepatocellular Carcinoma
16%
Liver Cirrhosis
16%
Liver Disease
16%
Awareness
16%
Chronic Liver Disease
16%
Diseases
16%
Pharmacology, Toxicology and Pharmaceutical Science
Prevalence
100%
Hepatitis B Virus
100%
Chronic Hepatitis B
100%
Liver Cell Carcinoma
16%
Liver Cirrhosis
16%
Liver Disease
16%
Chronic Liver Disease
16%
Elimination
16%
Diseases
16%